Radiomics Biomarkers Correlate with CD8 Expression and Predict Immune Signatures in Melanoma Patients.
Saved in:
| Title: | Radiomics Biomarkers Correlate with CD8 Expression and Predict Immune Signatures in Melanoma Patients. |
|---|---|
| Authors: | Aoude LG; The University of Queensland Diamantina Institute, The University of Queensland, Woolloongabba, Queensland, Australia. l.aoude@uq.edu.au., Wong BZY; Princess Alexandra Hospital, Department of Medical Imaging, Woolloongabba, Queensland, Australia.; Department of Medical Imaging, Gold Coast University Hospital, Southport, Australia., Bonazzi VF; The University of Queensland Diamantina Institute, The University of Queensland, Woolloongabba, Queensland, Australia., Brosda S; The University of Queensland Diamantina Institute, The University of Queensland, Woolloongabba, Queensland, Australia., Walters SB; School of Biomedical Sciences, The University of Queensland, St Lucia, Queensland, Australia., Koufariotis LT; QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia., Naeini MM; QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia., Pearson JV; QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia., Oey H; The University of Queensland Diamantina Institute, The University of Queensland, Woolloongabba, Queensland, Australia., Patel K; The University of Queensland Diamantina Institute, The University of Queensland, Woolloongabba, Queensland, Australia., Bradford JJ; The University of Queensland Diamantina Institute, The University of Queensland, Woolloongabba, Queensland, Australia., Bloxham CJ; The University of Queensland Diamantina Institute, The University of Queensland, Woolloongabba, Queensland, Australia., Atkinson V; Queensland Melanoma Project, Princess Alexandra Hospital, Woolloongabba, Queensland, Australia.; Faculty of Medicine, University of Queensland, St Lucia, Queensland, Australia., Law P; Princess Alexandra Hospital, Department of Medical Imaging, Woolloongabba, Queensland, Australia., Strutton G; Department of Anatomical Pathology, Princess Alexandra Hospital, Woolloongabba, Queensland, Australia., Bayley G; Queensland Melanoma Project, Princess Alexandra Hospital, Woolloongabba, Queensland, Australia., Yang S; Queensland Melanoma Project, Princess Alexandra Hospital, Woolloongabba, Queensland, Australia., Smithers BM; Queensland Melanoma Project, Princess Alexandra Hospital, Woolloongabba, Queensland, Australia.; Faculty of Medicine, University of Queensland, St Lucia, Queensland, Australia., Waddell N; QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia., Miles K; Princess Alexandra Hospital, Department of Medical Imaging, Woolloongabba, Queensland, Australia., Barbour AP; The University of Queensland Diamantina Institute, The University of Queensland, Woolloongabba, Queensland, Australia.; Queensland Melanoma Project, Princess Alexandra Hospital, Woolloongabba, Queensland, Australia. |
| Source: | Molecular cancer research : MCR [Mol Cancer Res] 2021 Jun; Vol. 19 (6), pp. 950-956. Date of Electronic Publication: 2021 Apr 02. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101150042 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3125 (Electronic) Linking ISSN: 15417786 NLM ISO Abbreviation: Mol Cancer Res Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
